@article{8307adde04534327908b26e091afd8f2,
title = "The COPD foundation coronavirus disease 2019 international medical experts survey: Results",
abstract = "Abbreviations: severe acute respiratory syndrome coronavirus 2, SARS-CoV-2; coronavirus disease 2019, COVID-19; Medical and Scientific Advisory Committee, MASAC; chronic obstructive pulmonary disease, COPD; World Health Organization, WHO; Centers for Disease Control and Prevention, CDC; acute respiratory distress syndrome, ARDS; Middle East respiratory syndrome, MERS; severe acute respiratory syndrome, SARS.",
keywords = "COVID-19, Coronavirus disease 2019, Discharge, Medical experts, Steroids",
author = "Ruth Tal-Singer and Yawn, \{Barbara P.\} and Robert Wise and Thomashow, \{Byron M.\} and Boyce, \{Danielle M.\}",
note = "Funding Information: Dr. Tal-Singer is a former employee and current shareholder of GlaxoSmithKline and has received personal fees from Vocalis Health and Immunomet outside of the submitted work. Dr. Yawn reports personal fees and non-financial support from Boehringer Ingelheim and personal fees from AstraZeneca, GlaxoSmithKline, and Novartis outside the submitted work. Dr. Thomashow is co-founder and former Chair of the Board of Directors for the COPD Foundation and currently serves as its Chief Medical Officer. He has served as a consultant for Boehringer Ingelheim and served on advisory boards for GlaxoSmithKline and AstraZeneca. Dr. Wise reports grants and personal fees from AstraZeneca/Medimmune, GlaxoSmithKline, Novartis and Boehringer-Ingelheim, personal fees from Contrafect, PulmonX, Roche / Genentech, Spiration, Pneuma, Verona, Bonti, Denali, Aradigm, Mylan, Theravance, Propeller Health, Kiniksa, Sunovion, Merck, and Circassia; and grants from Pearl Therapeutics, outside the submitted work. Ms. Boyce has nothing to declare. Publisher Copyright: {\textcopyright} 2019 Via Medica. All rights reserved.",
year = "2020",
doi = "10.15326/jcopdf.7.3.2020.0164",
language = "English (US)",
volume = "7",
journal = "Chronic Obstructive Pulmonary Diseases",
issn = "2372-952X",
publisher = "COPD Foundation",
number = "3",
}